Famon Awal Bros Sedaya Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Famon Awal Bros Sedaya has been growing earnings at an average annual rate of 1.8%, while the Healthcare industry saw earnings growing at 3.7% annually. Revenues have been growing at an average rate of 10.8% per year. Famon Awal Bros Sedaya's return on equity is 8%, and it has net margins of 12.7%.
Belangrijke informatie
1.8%
Groei van de winst
-0.4%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 14.1% |
| Inkomstengroei | 10.8% |
| Rendement op eigen vermogen | 8.0% |
| Nettomarge | 12.7% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Famon Awal Bros Sedaya geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 2,036,954 | 259,500 | 321,025 | 0 |
| 30 Jun 24 | 1,996,376 | 248,883 | 314,227 | 0 |
| 31 Mar 24 | 1,925,246 | 205,832 | 302,929 | 0 |
| 31 Dec 23 | 1,839,233 | 216,974 | 292,270 | 0 |
| 30 Sep 23 | 1,759,233 | 191,654 | 319,436 | 0 |
| 30 Jun 23 | 1,659,834 | 117,186 | 306,666 | 0 |
| 31 Mar 23 | 1,571,056 | 97,166 | 297,438 | 0 |
| 31 Dec 22 | 1,522,624 | 62,503 | 286,752 | 0 |
| 31 Dec 21 | 1,826,014 | 325,959 | 232,017 | 0 |
| 31 Dec 20 | 1,337,747 | 282,215 | 161,276 | 0 |
| 31 Dec 19 | 1,014,975 | 122,204 | 139,788 | 0 |
Kwaliteitswinsten: PRAY has high quality earnings.
Groeiende winstmarge: PRAY's current net profit margins (12.7%) are higher than last year (10.9%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: PRAY's earnings have grown by 1.8% per year over the past 5 years.
Versnelling van de groei: PRAY's earnings growth over the past year (35.4%) exceeds its 5-year average (1.8% per year).
Winst versus industrie: PRAY earnings growth over the past year (35.4%) exceeded the Healthcare industry 2.7%.
Rendement op eigen vermogen
Hoge ROE: PRAY's Return on Equity (8%) is considered low.